COVID-19 Booster Readiness Survey
1 other identifier
interventional
12,036
1 country
1
Brief Summary
The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2022
CompletedSeptember 30, 2022
September 1, 2022
14 days
September 1, 2022
September 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Count of employees who indicate interest in the booster
Number of employees who indicate that they plan to get the booster when it is available
14 days
Study Arms (4)
Standard question
NO INTERVENTIONQuestion with no additional text or framing
Question with salient Omicron message
EXPERIMENTALQuestion indicates that the bivalent booster can protect the respondent from the Omicron variant
Question with patient protection message
EXPERIMENTALQuestion indicates that the bivalent booster can protect patients (only presented to patient-facing employees)
Question with salient Omicron and patient protection message
EXPERIMENTALQuestion indicates that the bivalent booster can protect patients from the Omicron variant (only presented to patient-facing employees)
Interventions
The message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster
The message makes a reference to protecting one's self
The message makes a reference to protecting others (patients)
Eligibility Criteria
You may qualify if:
- Employee at the health system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geisinger Cliniclead
Study Sites (1)
Geisinger Clinic
Danville, Pennsylvania, 17822, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle N Meyer, PhD
Geisinger Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not know that there are different versions of surveys
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Faculty Co-Director, Behavioral Insights Team, Geisinger Clinic
Study Record Dates
First Submitted
September 1, 2022
First Posted
September 6, 2022
Study Start
September 1, 2022
Primary Completion
September 15, 2022
Study Completion
September 15, 2022
Last Updated
September 30, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- By the paper's online publication date. Data will remain available for as long as the Open Science Framework hosts it.
- Access Criteria
- The data on the Open Science Framework will be open to anyone requesting that information.
Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.